Compare Nuvalent Inc (NUVL) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Revvity Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Revvity Inc trades at $110.7 (market cap $11.87B). The key difference: Revvity Inc is the larger of the two by market cap, and Revvity Inc pays a 0.26% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | RVTY | |
|---|---|---|
Market Cap | $9.81B | $11.87B |
Sector | Technology | Technology |
52-Week High | $123.96 | $117.75 |
52-Week Low | $72.16 | $82.26 |
Enterprise Value | $8.52B | $14.36B |
Dividend Yield | — | 0.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
